BRIP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62836411021772E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.9013237085328E-13 |
Normal-vs-Stage2 |
2.1260000000467E-06 |
Normal-vs-Stage3 |
7.57410023588534E-10 |
Normal-vs-Stage4 |
1.26869999950152E-07 |
Stage1-vs-Stage2 |
5.419200E-01 |
Stage1-vs-Stage3 |
9.812800E-01 |
Stage1-vs-Stage4 |
1.379360E-01 |
Stage2-vs-Stage3 |
5.882000E-01 |
Stage2-vs-Stage4 |
8.459600E-02 |
Stage3-vs-Stage4 |
1.597600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62492241884138E-12 |
Normal-vs-AfricanAmerican |
4.379100E-04 |
Normal-vs-Asian |
8.550200E-02 |
Caucasian-vs-AfricanAmerican |
1.2239000000136E-06 |
Caucasian-vs-Asian |
5.054200E-01 |
AfricanAmerican-vs-Asian |
2.355600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.63042929052426E-14 |
Normal-vs-Female |
1.52480250648068E-11 |
Male-vs-Female |
7.854800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.71900000000203E-05 |
Normal-vs-Age(41-60Yrs) |
2.13051798425568E-12 |
Normal-vs-Age(61-80Yrs) |
8.18012324543815E-13 |
Normal-vs-Age(81-100Yrs) |
1.70153999999867E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.780600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.182200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.713600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.871800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.174000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.992800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.315800E-03 |
Normal-vs-Grade 2 |
4.31010782619978E-12 |
Normal-vs-Grade 3 |
1.71895830902713E-12 |
Normal-vs-Grade 4 |
2.76359999995535E-06 |
Grade 1-vs-Grade 2 |
1.041780E-01 |
Grade 1-vs-Grade 3 |
6.079600E-02 |
Grade 1-vs-Grade 4 |
4.036300E-02 |
Grade 2-vs-Grade 3 |
7.728000E-01 |
Grade 2-vs-Grade 4 |
2.371800E-01 |
Grade 3-vs-Grade 4 |
2.848600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.50750547997814E-14 |
Normal-vs-ccB subtype |
1.16269993633011E-10 |
ccA subtype-vs-ccB subtype |
3.426800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.6894263765721E-12 |
Normal-vs-N1 |
5.962200E-04 |
N0-vs-N1 |
1.195580E-01 |
|
|